SEC Filings for Ayala Pharmaceuticals, Inc.
425 - Prospectuses and communications, business combinations
Form Type: 425
Filing Date: 2021-12-02
View Filing
DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Form Type: DEFA14A
Filing Date: 2021-11-24
View Filing
8-K - Current report
Form Type: 8-K
Filing Date: 2021-11-22
View Filing
425 - Prospectuses and communications, business combinations
Form Type: 425
Filing Date: 2021-11-22
View Filing
DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Form Type: DEFA14A
Filing Date: 2021-11-22
View Filing
DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Form Type: DEFA14A
Filing Date: 2021-11-18
View Filing
8-K - Current report
Form Type: 8-K
Filing Date: 2021-11-17
View Filing
425 - Prospectuses and communications, business combinations
Form Type: 425
Filing Date: 2021-11-15
View Filing
8-K - Current report
Form Type: 8-K
Filing Date: 2021-11-15
View Filing
425 - Prospectuses and communications, business combinations
Form Type: 425
Filing Date: 2021-11-09
View Filing
